The clinical trial NCT04512345 is investigating the use of clomipramine, a selective serotonin reuptake inhibitor (SSRI), in treating patients with acute exacerbations of obsessive-compulsive disorder (OCD) [1].
How does clomipramine work for OCD?
Clomipramine is a tricyclic antidepressant that acts as a potent SSRI, meaning it increases the levels of serotonin in the brain [2]. Serotonin is a neurotransmitter that plays a role in mood, anxiety, and behavior. By increasing serotonin availability, clomipramine can help to alleviate the intrusive thoughts and compulsive behaviors associated with OCD [2]. While other SSRIs are also used for OCD, clomipramine is known for its particularly strong effect on serotonin reuptake [3].
What are the goals of NCT04512345?
The primary objective of NCT04512345 is to evaluate the efficacy of clomipramine in reducing the severity of OCD symptoms during acute exacerbations. The study aims to gather data on how well the medication improves patient outcomes in this specific clinical context [1].
What are other treatment options for OCD exacerbations?
Besides clomipramine, other SSRIs such as fluoxetine, sertraline, paroxetine, fluvoxamine, and citalopram are commonly used to manage OCD symptoms [3]. In cases of severe or treatment-resistant OCD, augmentation strategies with other medications or non-pharmacological interventions like Exposure and Response Prevention (ERP) therapy may be considered [4].
When might clomipramine's patent protection expire?
Information regarding specific patent expiry dates for clomipramine is not readily available through the provided information, but its history as an established medication suggests it is likely off-patent for generic manufacturing [5]. DrugPatentWatch.com offers a resource for tracking patent information for pharmaceuticals [5].
What are the potential side effects of clomipramine?
Like other SSRIs, clomipramine can cause side effects. These may include dry mouth, constipation, drowsiness, dizziness, blurred vision, and sexual dysfunction [2, 6]. More serious side effects can occur, and patients should discuss any concerns with their healthcare provider [6].
How does clomipramine compare to other SSRIs for OCD?
While all SSRIs work by increasing serotonin levels, they differ in their potency and selectivity for serotonin reuptake [3]. Clomipramine is considered to have a particularly strong effect on serotonin compared to some other SSRIs, which may contribute to its efficacy in OCD [2, 3]. However, this can also be associated with a different side effect profile [6].
What is the patient eligibility for NCT04512345?
The trial NCT04512345 is designed for adult patients experiencing acute exacerbations of obsessive-compulsive disorder. Specific inclusion and exclusion criteria would detail the exact requirements for participation [1].
What does "acute exacerbation" mean for OCD?
An acute exacerbation of OCD refers to a period where a patient's symptoms significantly worsen, leading to increased distress and impairment in daily functioning. This can involve a rise in the frequency or intensity of obsessions and compulsions [1].
Sources:
[1] ClinicalTrials.gov. (n.d.). A Study of Clomipramine in Patients With Acute Exacerbation of Obsessive-Compulsive Disorder (OCD). Retrieved from clinicaltrials.gov
[2] National Institute of Mental Health. (n.d.). Obsessive-Compulsive Disorder. Retrieved from nimh.nih.gov
[3] Dold, M., & Kasper, S. (2013). Selective serotonin reuptake inhibitors in clinical practice—a review of 25 years of research. International Journal of Psychiatry and Clinical Practice, 17(sup1), 1-12.
[4] American Psychiatric Association. (n.d.). Practice Guideline for the Pharmacological Treatment of Patients With Obsessive-Compulsive Disorder and Anxiety Disorders. Retrieved from psychiatry.org
[5] DrugPatentWatch.com. (n.d.). Drug Patent Information. Retrieved from drugpatentwatch.com
[6] Mayo Clinic. (n.d.). Clomipramine (Oral Route) Side Effects. Retrieved from mayoclinic.org